Resmi büyüt: Ege Can Şerefoğlu, Üroloji İstanbul

Prof. Dr. Ege Can Şerefoğlu

Üroloji · Daha fazla

İstanbul 1 adres

5 görüş
İletişim Bilgileri

Özgeçmiş

1979 yılında İskenderun’da doğan ve Hacettepe Üniversitesi Tıp Fakültesini 2003 yılında bitiren Dr.Şerefoğlu, aynı yıl İstanbul Üniversitesi Tıp Fakültesi Genel Cerrahi A.B.D.’da ihtisas eğitimine başladı. Haziran 2004 tarihinden sonra Ankara Atatürk Eğitim ve Araştırma Hastanesi, Üroloji Bölümünde ihtisasına devam etti ve Nisan 2009’da üroloji uzmanı oldu.

İhtisası sırasında Androloji alanında yaptığı çalışmaları yurt içi ve yurt dışında yayınlama imkanı bulan Dr. Şerefoğlu, eğitimi sırasında Hacettepe Üniversitesi Tıp Fakültesi ve Radboud Üniversitesi Üroloji Bölümünde (Hollanda) çocuk ürolojisi üzerine çalıştı.

Devlet Hizmet Yükümlüsü olarak atandığı Mardin Kızıltepe Devlet Hastanesi’nde 2 sene görev yaptıktan sonra Tulane Üniversitesi Tıp Fakültesinde (ABD) Androloji alanında çalışmaya başladı. Birçok ulusal ve uluslar arası üroloji derneğine üye olan Dr.Şerefoğlu aynı zamanda Avrupa Cinsel Sağlık Derneği (ESSM) Bilimsel Komitesi, Uluslar Arası Cinsel Sağlık Derneği (ISSM) Strateji ve Geliştirme Komitesi ve Avrupa Üroloji Derneği Genç Akademik Üroloji Çalışma Grubu üyesidir. Çalışmaları nedeniyle 2012 yılında “Amsterdam Genç Bilim Adamı” ödülüne layık görülmüştür.
daha fazla Hakkımda

Hakkımda

1979 yılında İskenderun’da doğan ve Hacettepe Üniversitesi Tıp Fakültesini 2003 yılında bitiren Dr.Şerefoğlu, aynı yıl İstanbul Üniversitesi Tıp Fakültesi Genel Cerrahi A.B.D.’da ihtisas eğitimine başladı. Haziran 2004 tarihinden sonra Ankara Atatürk Eğitim ve Araştırma Hastanesi, Üroloji Bölümünde ihtisasına devam etti ve Nisan 2009’da üroloji uzmanı oldu.

İhtisası sırasında Androloji alanında yaptığı çalışmaları yurt içi ve yurt dışında yayınlama imkanı bulan Dr. Şerefoğlu, eğitimi sırasında Hacettepe Üniversitesi Tıp Fakültesi ve Radboud Üniversitesi Üroloji Bölümünde (Hollanda) çocuk ürolojisi üzerine çalıştı.

Devlet Hizmet Yükümlüsü olarak atandığı Mardin Kızıltepe Devlet Hastanesi’nde 2 sene görev yaptıktan sonra Tulane Üniversitesi Tıp Fakültesinde (ABD) Androloji alanında çalışmaya başladı. Birçok ulusal ve uluslar arası üroloji derneğine üye olan Dr.Şerefoğlu aynı zamanda Avrupa Cinsel Sağlık Derneği (ESSM) Bilimsel Komitesi, Uluslar Arası Cinsel Sağlık Derneği (ISSM) Strateji ve Geliştirme Komitesi ve Avrupa Üroloji Derneği Genç Akademik Üroloji Çalışma Grubu üyesidir. Çalışmaları nedeniyle 2012 yılında “Amsterdam Genç Bilim Adamı” ödülüne layık görülmüştür.

Başlıca İlgi Alanları

Özgeçmiş

Doctor
Ege Can Şerefoğlu

Üroloji, Androloji, Üreme Endokrinolojisi Ve İnfertilite

5 görüş

Uzmanlık alanları

  • Üroloji
  • Androloji
  • Üreme endokrinolojisi ve i̇nfertilite

Deneyimler

  • Uzm.Dr. Bağcılar Eğitim & Araştırma Hastanesi, Üroloji Kliniği, İstanbul 2013 -
  • Uzm.Dr. Medicana International Ankara Hastanesi, Ankara 2012-2013
  • Dr.Ar.Gör. Tulane Üniversitesi Tıp Fakültesi, Üroloji A.B.D., New Orleans, LA, ABD 2011-2012
  • Uzm.Dr. Kızıltepe Devlet Hastanesi, Mardin 2009-2011
  • Dr.Ar.Gör. Atatürk Eğitim & Araştırma Hastanesi, Üroloji Kliniği, Ankara 2004-2009
  • Ar.Gör. Genel Cerrahi A.B.D., İstanbul Tıp Fakültesi, İstanbul Üniversitesi 2003-2004
Tümünü göster

Okullar / eğitimler

  • Doçentlik Üroloji Bağcılar Eğitim & Araştırma Hastanesi 2014
  • Tıpta Uzmanlık Üroloji Atatürk Eğitim & Araştırma Hastanesi 2009
  • Lisans Tıp Fakültesi Hacettepe Üniversitesi 2003

İlgi alanları

Tümünü göster

Yayınlar

  • A114. “The Awareness of Patients with Non-Muscle Invasive Bladder Cancer Regarding the Importance of Smoking Cessation and Their Access to Smoking Cessation Programs,” Yuruk E, Tuken M, Colakerol A, Serefoglu EC. (Int Braz J Urol dergisinde yayına kabul edilmiştir)
  • A113. Invited Commentary on "Post-orgasmic illness syndrome: Where are we?” Serefoglu EC. (J Sex Med dergisinde yayına kabul edilmiştir)
  • A112. “Sexual Function may be Impaired During Pregnancy in Adolescent Women,” Tasdemir N, Celik C, Abali R, Ozer I, Culha MG, Serefoglu EC. (Sex Relation Ther dergisinde yayına kabul edilmiştir)
  • A111. “Commentary: Prolonged Exposure to Acetaminophen During Pregnancy Reduces Testosterone Production by the Human Fetal Testis,” Culha MG, Serefoglu EC (Ann Transl Med dergisinde yayına kabul edilmiştir)
  • A110. “Post-Finasteride Syndrome: An underestimated phenomenon,” Cakir OO, Serefoglu EC. Urol Androl Open J. 2016; 1(1): e3-e4.
  • A109. “Urogenital Myiasis Caused by Psychoda Albipennis: A Case Report,” Culha MG, Turker K, Ozsoy S, Serefoglu EC (Saudi Medical Journal dergisinde yayına kabul edilmiştir)
  • A108. Editorial comment regarding "Multivariate analyses of the factors associated with sexual intercourse, marriage, and paternity of hypospadias patients,” Serefoglu EC J Sex Med. 2016 Oct;13(10):1496.
  • A107. “Glucagon Like Peptide-1 Receptor Agonists May Ameliorate The Metabolic Adverse Effect Associated With Antiretroviral Therapy,” Culha MG, Inkaya AC, Yildirim E, Unal S, Serefoglu EC. Med Hypotheses. 2016 Sep;94:151-3.
  • A106. “Diabetes and Sexuality,” Kiziliay F, Gali HE, Serefoglu EC (Accepted for publication in the Sexual Medicine Reviews)
  • A105. “The Association Between Seminal Vesicle Size and Duration of Abstinence from Ejaculation,” Yuruk E, Pastuszak AW, Suggs JM, Colakerol A, Serefoglu EC (Accepted for publication in the Andrologia)
  • A104. “Sexuality following Radical Prostatectomy: Is Restoration of Erectile Function Enough?” Fode M, Albersen M, Serefoglu EC (Accepted for publication in the Sexual Medicine Reviews)
  • A103. “Computerized tomography attenuation values can be used to differentiate hydronephrosis from pyonephrosis,” Yuruk E, Tuken M, Sulejman S, Colakerol A, Serefoglu EC, Sarica K, Muslumanoglu AY. (Accepted for publication in the World J Urol)
  • A102. “Neutrophil to lymphocyte ratio is elevated in recurring non-muscle invasive bladder cancer,” Yuruk E, Gonultas S, Serefoglu EC, Muslumanoglu AY (Accepted for publication in the Turkish Journal of Medical Sciences)
  • A101. “Retrograde Ejaculation, Painful Ejaculation and Haematospermia,” Parnham A, Serefoglu EC. Transl Androl Urol. 2016 Aug;5(4):592-601.
  • A100. “Classification and definition of premature ejaculation,” Parnham A, Serefoglu EC Transl Androl Urol. 2016 Aug;5(4):416-23.
  • A99. “The Epidemiology of Premature Ejaculation,” Saitz TR, Serefoglu EC. Transl Androl Urol. 2016 Aug;5(4):409-15.
  • A98. “The Attitudes of Sexual medicine Specialists Towards Premature Ejaculation Diagnosis and Therapy,” Lowenstein L, Shechter A, Serefoglu EC, Reisman Y. Sex Med. 2016 Sep;4(3):e209-16.
  • A97. “A novel dosimeter for measuring radiation exposure during percutaneous nephrolithotomy: Instadose™," Yuruk E, Gureser G, Tuken M, Ertas K, Serefoglu EC. Cent Uropean J Urol. 2016;69(2):198-203.
  • A96. “On-Demand Modafinil Improves Ejaculation Time and Patient Reported Outcomes in Men with Lifelong Premature Ejaculation” Tuken M, Kiremit MC, Serefoglu EC. Urology. 2016 Aug;94:139-42.
  • A95. “Global minimally invasive pyeloplasty study in children: results from the pediatric urology expert group of the EAU young academic urologists working party,” MS Silay, R Kocvara, S Undre, AF Spinoit, G Grimsby, T Garmanova, Tandogdu Z, Guttila A, Sancaktutar AA, Haid B, Waldert M, Goyal A, Serefoglu EC, Baldassare E, Manzoni G, Radford A, Subramaniam R, Fiala V, Cheriam A, Hoebeke P, Gargollo P, Yuriy R, Zattoni F, Koh C. J Pediatr Urol. 2016 Aug;12(4):229.e1-7.
  • A94. “Delay Of Surgical Treatment Of Penile Fracture Results In Poor Functional Outcome: Results From A Large Retrospective Multicentric European Study,” Bozzini G, Albersen M, Romero Otero J, Margreiter M, Garcia Cruz E, Mueller A, Gratzke C, Serefoglu EC, Martinez Salamanca JI, Verze P. (Accepted for publication in the EU Focus)
  • A93. “Catheter dwell time and diameter affect the recurrence rates after internal urethrotomy,” Yuruk E, Yentur S, Cakir OO, Ertas K, Serefoglu EC, Semercioz A. Turk J Urol. 2016 Sep;42(3):184-9.
  • A92. “Preserving Erectile Function After Robot Assisted Radical Prostatectomy," Culha MG, Serefoglu EC (Robotics & Laparoscopy e-dergisinde yayına kabul edilmiştir)
  • A91. “The Accuracy of References in The Journal of Urology” Cimen HI, Saitz TR, Serefoglu EC. J Urol. 2016 Jun;195(6):1952-5.
  • A90. “Feasibility and safety of conservative surgery for the treatment of spermatic cord leiomyosarcoma,” Bozzini G, Albersen M, Romero Otero J, Margreiter M, Garcia Cruz E, Mueller A, Gratzke C, Serefoglu EC, Martinez Salamanca JI, Verze P. Int J Surg. 2015 Nov 11. pii: 01316-3.
  • A89. “The Effects of Four Different Suture Materials on Penile Tissue of Rats,” Tuken M, Altinay S, Temiz MZ, Cakir OO, Aykan S, Semercioz A, Serefoglu EC. Int J Impot Res. 2016 Mar-Apr;28(2):50-3.
  • A88. “Advances in understanding and treating premature ejaculation,” Saitz TR, Serefoglu EC. Nat Rev Urol. 2015 Nov;12(11):629-40.
  • A87. “HIV and Men," Cimen HI, Parnham AS, Serefoglu EC. (Sexual Medicine Reviews dergisinde yayına kabul edilmiştir)
  • A86. “Re: Effect of Tadalafil Once Daily on Penile Length Loss and morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results from a Randomized Controlled Trial,” Culha MG, Pastuszak A, Serefoglu EC. Urology. 2015 Dec;86(6):1242-3.
  • A85. “Entecavir Treatment may be Associated with Decreased Libido in Male Patients with Chronic Hepatitis B: Report of 2 Cases,” Turker K, Sonbahar E, Serefoglu EC, Fidan MK, Vardar MK. Andrologia. 2016 Jun;48(5):605-606.
  • A84. “Commentary on: Sildenafil citrate improves erectile function after castration in a rat model.” Serefoglu EC. Sex Med 2015;3:1–6
  • A83. “Commentary on: Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: The Radiation Therapy Oncology Group [0831] randomized clinical trial.” Serefoglu EC. Sex Med 2015;3:1–6
  • A82. “Commentary on: Efficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia.” Serefoglu EC. Sex Med 2015;3:1–6
  • A81. “Commentary on: Does surgeon subjective nerve sparing score predict recovery time of erectile function following robot-assisted radical prostatectomy?” Serefoglu EC. J Sex Med. 12(6):1497-8, 2015.
  • A80. “On-Demand D-Modafinil may be an Effective Treatment Option for Lifelong Premature Ejaculation: A Case Report,” Serefoglu EC. Andrologia. 2016 Feb;48(1):121-2.
  • A79. “Sexual Dysfunction in 2014: Men enjoy a year of significant progress” Saitz TR, Serefoglu EC. Nat Rev Urol. 12(2):73-4, 2015.
  • A78. “The Direction and Severity of Penile Curvature Does Not Have an Impact on Concomitant Vasculogenic Erectile Dysfunction in Patients with Peyronie's Disease” Serefoglu EC, Trost L, Sikka SC, Hellstrom WJG. Int J Impot Res. 27(1):6-8, 2015
  • A77. “Re: Associations Between Premature Ejaculation, Lower Urinary Tract Symptoms, and Erectile Dysfunction in Middle-Aged Korean Policemen” Dincer M, Serefoglu EC. J Sex Med. 11(8):2125, 2014.
  • A76. “Advances in Treating Premature Ejaculation,” Cayan S, Serefoglu EC. F1000Prime Rep. 8;6:55, 2014.
  • A75. “Is There a Correlation Between Intravaginal Ejaculatory Latency Time and Enuresis? An Exploratory Study” Koyuncu H, Serefoglu EC, Karacay S, Ozdemir AT, Kalkan M, Yencilek F. Cent European J Urol 67: 74-78, 2014.
  • A74. The Incidence of Postoperative Ileus in Patients who Underwent Robotic Assisted Radical Prostatectomy,” Ozdemir AT, Altinova S, Koyuncu H, Serefoglu EC, Cimen HI, Balbay MD. Cent European J Urol 67: 19-24, 2014.
  • A73. An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the International Society for Sexual Medicine (ISSM) Second Ad Hoc Committee for the Definition of Premature Ejaculation,” Serefoglu EC, Althof SE, McMahon CG, Waldinger MD, Shindel A, Adaikan G, Becher E, Dean J, Giuliano F, Hellstrom WJG, Giraldi A, Glina S, Incrocci L, Jannani E, McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, Torres LO. J Sex Med. 11(6):1423-41, 2014.
  • A72. “What Can Be Done to Maintain Men’s Health: Perspectives from the EAU Young Academic Urologists Working Party (YAUWP) Men's Health Group,” Serefoglu EC, Gratzke C, Verze P. Eur Urol. pii: 00315-7, 2014.
  • A71. “An Update of the International Society of Sexual Medicine’s Guidelines for the Diagnosis and Treatment of Premature Ejaculation,” Althof SE, McMahon CG, Waldinger MD, Serefoglu EC, Shindel A, Adaikan G, Becher E, Dean J, Giuliano F, Hellstrom WJG, Giraldi A, Glina S, Incrocci L, Jannani E, McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, Torres LO. J Sex Med. 11(6):1392-422, 2014.
  • A70. “Dapoxetine and the treatment of premature ejaculation,” Sangkum P, Badr R, Serefoglu EC, Hellstrom WJG. Transl Androl Urol, 2(4):301-311, 2013
  • A69. “Editorial Comment: The 5-HT2C Receptor Gene Cys23Ser Polymorphism influences the Intravaginal Ejaculation Latency Time in Dutch Caucasian Men with Lifelong Premature Ejaculation,” Saitz TR, Serefoglu EC. Asian J Androl. 16(4):643, 2014.
  • A68. “Effect of Botulinum-A Toxin Injection into Bulbospongiosus Muscle on Ejaculation Latency in Male Rats,” Serefoglu EC, Hawley WR, Lesker GF, Grissom EM, Sikka SC, Dohanich GP, Hellstrom WJG. J Sex Med. 11(7):1657-63, 2014.
  • A67. “RE: Baseline Characteristics from an Ongoing Phase 3 Study of Collagenase Clostridium Histolyticum in Patients with Peyronie’s Disease,” Dincer M, Serefoglu EC. J Sex Med. 11(5):1350, 2014.
  • A66. “RE: Peyronie’s disease plaque calcification – prevalence, time to identification, and development of a new grading calcification,” Yuruk E, Serefoglu EC. J Sex Med. 11(5):1351, 2014.
  • A65. “Re: The global online sexuality survey (GOSS): The United States of America in 2011 Chapter III--Premature ejaculation among English-speaking male Internet users,” Saitz TR, Serefoglu EC. J Sex Med 11(5): 1349-50, 2014.
  • J Clin Anal Med. 5(3): 188-92, 2014.
  • A64. “Factors Predictive of Pain During Cystoscopy: A Prospective Study,” Ozdemir AT, Altinova S, Koyuncu HH, Serefoglu EC, Balbay MD.
  • A63. “Re- Pharmaco-induced Erections for Penile Color Doppler Ultrasound: Oral PDE5 Inhibitors or Intracavernosal Injection?,” Akcay M, Serefoglu EC. IJIR 26(3): 120, 2014.
  • A62. “The Pre-Treatment Prevalence and Types of Sexual Dysfunction Among Patients Diagnosed with Prostate Cancer” Saitz TR, Serefoglu EC, Trost L, Hellstrom WJG. Andrology 1(6): 859-63, 2013.
  • A61. “Erectile Function Outcomes after Robot-Assisted Radical Prostatectomy: Is It Superior to Open Retropubic or Laparoscopic Approach?," Isgoren AE, Saitz TR, Serefoglu EC. Sexual Medicine Reviews 2(1): 10-24, 2014.
  • A60. “Chronic escitalopram treatment induces erectile dysfunction by decreasing nitric oxide bioavailability mediated by increased NADPH oxidase activity and ROS production,” Kassan M, Lasker GF, Sikka SC, Mandava SH, Gokce A, Matrougui K, Hellstrom WJG, Kadowitz PJ, Serefoglu EC. Urology 82(5): 1188, 2013.
  • A59. “Are Expensive Instruments Necessary for Transobturator Tape Operations?” Ozdemir AT, Altinova S, Serefoglu EC, Gurdal M. Journal of Clinical and Analytical Medicine 4(1): 19-22, 2013.
  • A58. “An unexpected reason of urinary leakage after radical cystectomy and orthotopic urinary diversion,” Ozdemir AT, Serefoglu EC, Altinova S, Akbulut Z, Balbay MD. Journal of Clinical and Analytical Medicine. 3(3);336-7, 2011.
  • A57. “IFN alpha-2B and BCG therapy is an effective method in superficial bladder carcinoma,” Ozdemir AT, Altinova S, Serefoglu EC. Journal of Clinical and Analytical Medicine 3(2): 155-8, 2012.
  • A56. “RE: The prevalence of premature ejaculation and its clinical characteristics in Korean men according to different definitions” Saitz TR, Serefoglu EC. Int J Impot Res, 25(4):160, 2013.
  • A55. “Premature ejaculation: do we have effective therapy?,” Serefoglu EC, Saitz TR, Trost L, Hellstrom WJ. Transl Androl Urol, 2(1):45-53, 2013.
  • A54. “Is placement of pelvic drain indispensible after radical cystectomy, extended lymph node dissection and orthotopic neobladder substitution?,” Ozdemir AT, Altinova S, Serefoglu EC, Atmaca AF, Balbay MD. Turk J Med Sci, 43:263-7, 2013.
  • A53. “Understanding the Course of Peyronie’s Disease,” Garaffa G, Trost L, Serefoglu EC, Ralph D, Hellstrom WJG. Int J Clin Pract, 67(8):781-8, 2013.
  • A52. “RE: Long-Term Infection Outcomes of 3-Piece Antibiotic Impregnated Penile Prostheses Used in Replacement Implant Surgery,” Saitz TR, Serefoglu EC, Hellstrom WJG. J Urol, 189(5):1994-6, 2013.
  • A51. “Re: Prevalence of ejaculatory disorders in urban men-results of a random-sample survey” Gokce A, Serefoglu EC, Hellstrom WJG. Andrologia 44(6):365. 2012.
  • A50. “Androgen Deprivation Therapy Impact on QoL and Cardiovascular Health, Monitoring Therapeutic Replacement,” Trost LW, Serefoglu E, Gokce A, Linder BJ, Sartor AO, Hellstrom WJG. J Sex Med. 10(Suppl 1):84-101, 2013.
  • A49. “PDE5 Inhibitor Treatment Options for Urologic and Non-Urologic Indications: 2012 Update,” Gur S, Kadowitz PJ, Serefoglu EC, Hellstrom WJG. Curr Pharm Des 18(34):5590-606, 2012.
  • A48. “New Insights on Premature Ejaculation: A Review of Definition, Classification, Prevalence and Treatment,” Serefoglu EC, Saitz TR. AJA, 14(6):822-9, 2012
  • A47. “Adolescent Varicocele Management Controversies,” Serefoglu EC, Saitz TR, Hellstrom WJG. Andrology,1(1):109-15, 2013.
  • A46. “Sexual Dysfunction Following Radical Prostatectomy,” Benson CR, Serefoglu EC, Hellstrom WJG. J Androl, 33(6):1143-54, 2012.
  • A45. “A phase II, single-blind, randomized, crossover evaluation of the safety and efficacy of avanafil using visual sexual stimulation in patients with mild to moderate erectile dysfunction,” Hellstrom WJG, Freier MT, Serefoglu EC, Lewis RW, DiDonato K, Peterson CA. BJU International, 111(1):137-47, 2013.
  • A44. “Infection Retardant Coated Inflatable Penile Prostheses Reduce the Incidence of Infection: A Systematic Review and Meta-Analysis,” Mandava SH, Serefoglu EC, Freier MT, Wilson SK, Hellstrom WJG. J Urol, 188(5): .
  • A43. “Comparison of the Outcomes of the TOT Technique Using a Hand-Made TOT Material and a Commercial One,” Ozdemir AT, Altinova S, Cimen HI, Serefoglu EC, Koyuncu HH, Gurdal M. Turk J Med Sci, 42(Sup.1): 1230-1234, 2012.
  • A42. “Deleterious Effects of Selective Seratonin Re-uptake Inhibitors Treatment on Semen Parameters in Patients with lifelong Premature Ejaculation,” Koyuncu HH, Serefoglu EC, Ozdemir AT, Hellstrom WJG. IJIR, 24(5):171-3, 2012.
  • A41. “RE: Penile Doppler sonographic and clinical characteristics in Peyronie’s disease and/or erectile dysfunction: an analysis of 1500 men with sexual dysfunction,” Serefoglu EC, Mandava SH, Sikka SS, Hellstrom WJG. BJU Int, 110(3): 154-5, 2012.
  • A40. “Long-Term Revision Rate Due to Infection in Hydrophilic Coated Inflatable Penile Prostheses: 11-Year Follow-up,” Serefoglu EC, Mandava SH, Gokce A, Chouhan JD, Wilson SK, Hellstrom WJG. J Sex Med, 9(8): 2182-6, 2012.
  • A39. “Premature Ejaculation and Erectile Dysfunction Prevalence and Attitudes in the Asia-Pacific Region—A Comment,” Serefoglu EC, Direk N, Hellstrom WJG. J Sex Med, 9(5): 1488-9, 2012.
  • A38. “Comparison of Changes in Body Image of Patients with Renal Calculi Treated by Pyelolithotomy or Percutaneous Lithotripsy,” Aglamis E, Ceylan C, Altinova S, Serefoglu EC, Beytur A. Kuwait Medical Journal, 44 (2): 113 – 117, 2012.
  • A37. “Is sampling transitional zone in patients who had prior negative prostate biopsy necessary?” Dogan B, Serefoglu EC, Atmaca AF, Canda AE, Akbulut Z, Balbay MD. Int Urol Nephrol, 44(4): 1071-5, 2012.
  • A36. “Re: Porst H, Kim ED, Casabé AR, Mirone V, Secrest RJ, Xu L, Sundin DP, Viktrup L; LVHJ study team. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial,” Serefoglu EC, Mitchell GC, Hellstrom WJG. Eur Urol, 61(5):e45-6, 2012.
  • A35. “Re: An exploration of the association between male body mass index and semen quality,” Gokce A, Serefoglu EC, Hellstrom WJG. Reproductive BioMedicine Online, 24(4):482, 2012
  • A34. “Selenium and Lycopene Attenuate Cisplatin-Induced Testicular Toxicity Associated with Oxidative Stress in Winstar Rats,” Salem EA, Salem NA, Maarouf AM, Serefoglu EC, Hellstrom WJG. Urology, 79(5):1184.e1-6, 2012.
  • A33. “Re: Long-Term Infection Outcomes after Original Antibiotic Impregnated Inflatable Penile Prosthesis Implants: Up to 7.7 Years of Followup,” Serefoglu EC, Mandava SH, Hellstrom WJG. J Urol;187(5):1936-7, 2012.
  • A32. “Bother index can be used in deciding how the symptom nocturia itself is important clinically,” Ozdemir AT, Cimen HI, Altinova S, Atmaca AF, Serefoglu EC, Balbay MD. Turkish Journal of Medical Sciences, 42 (4):605-611, 2012.
  • A31. “How reliable is 12-core biopsy procedure in the detection of prostate cancer?,” Serefoglu EC, Altinova S, Ugras, NS, Akincioglu E, Asil E, Balbay MD. Can Urol Assoc J, 2:1-6, 2012.
  • A30. “The False Diagnosis of Venous Leak: Prevalence and Predictors-A Comment,” Serefoglu EC, Sikka S, Hellstrom WJG. J Sex Med. 9(1):332-3, 2012.
  • A29. “Treatment of Peyronie's Disease: 2012 Update,” Serefoglu EC, Hellstrom WJ. Curr Urol Rep. 12(6):444-52, 2011.
  • A28. “Escitalopram Treatment for Premature Ejaculation has a Negative Effect on Semen Parameters,” Koyuncu HH, Serefoglu EC, Yencilek E, Atalay H, Akbas N, Sarica K. IJIR. 23(6):257-61, 2011.
  • A27. “The Comparison of Premature Ejaculation Assessment Questionnaires and Their Sensitivity for the Four Premature Ejaculation Syndromes: Results from the Turkish Society of Andrology Sexual Health Survey‏,” Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, Ekmekcioglu O, Kendirci M, Semerci B, Kadioglu A. J Sex Med. 8(4):1177-85, 2011.
  • A26. “Prevalence of the Complaint of Ejaculating Prematurely and the Four Premature Ejaculation Syndromes: Results from the Turkish Society of Andrology Sexual Health Survey‏,” Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, Ekmekcioglu O, Kendirci M, Semerci B, Kadioglu A. J Sex Med. 8(2):540-8, 2011.
  • A25. “Efficacy and safety of zoledronic acid in the treatment of glucocorticoid induced osteoporosis,” Serefoglu EC, Tandogdu Z. Therapeutics and Clinical Risk Management. 25(6): 219-23, 2010.
  • A24. “The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes,” Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. J Sex Med. 7(2 Pt 1):810-5, 2010.
  • A23. “T-786C Polymorphism in promoter of eNOS gene as genetic risk factor in patients with erectile dysfunction in Turkish population,” Sinici I, Guven EO, Serefoglu EC, Hayran M. Urology. 75(4):955-60, 2010.
  • A22. “Factors affecting urethral stricture development after radical retropubic prostatectomy,” Altinova S, Serefoglu EC, Ozdemir AT, Atmaca AF, Akbulut Z, Balbay MD. Int Urol Nephrol. 41(4):881-4, 2009.
  • A21. “The Incidence and Management of Pleural Injuries Occurring during Open Nephrectomy,” Atmaca AF, Canda AE, Serefoglu EC, Altinova S, Ozdemir AT, Balbay MD. Adv Urol. 2009:948906.
  • A20. “The Actual Incidence of Papaverine Induced Priapism in Patients with Erectile Dysfunction Following Penile Color Doppler Ultrasonography,” Kilic M, Serefoglu EC, Ozdemir AT, Balbay MD. Andrologia. 42(1):1-4, 2010.
  • A19. “Botulinum toxin-A injection may be beneficial in the treatment of life-long premature ejaculation,” Serefoglu EC, Silay MS. Medical Hypotheses. 74(1):83-4, 2010.
  • A18. “Re: Does Previous Extracorporeal Shock Wave Lithotripsy Affect the Performance and Outcome of Percutaneous Nephrolithotomy?,” Cimen HI, Serefoglu EC, Balbay MD. J Urol. 182(5):2534-5, 2009.
  • A17. “Re: Renal Apoptosis Following Carbon Dioxide Pneumoperitoneum in a Rat Model,” Cimen HI, Serefoglu EC, Balbay MD. J Urol. 182(4):1654-5, 2009.
  • A16. “Re: Outcomes Following Partial Nephrectomy by Tumor Size,” Cimen HI, Serefoglu EC, Balbay MD. J Urol. 182(3):1232, 2009.
  • A15. “Re: High Anterior Release of the Levator Fascia Improves Sexual Function Following Open Radical Retropubic Prostatectomy,” Serefoglu EC, Atmaca AF, Balbay MD. J Urol. 182(2):805-6, 2009.
  • A14. “Slow Zoledronic Acid Releasing Testis Prostheses in the Treatment of Prostate Cancer Patients with Bone Metastases,” Serefoglu EC, Balbay MD. Medical Hypotheses. 73(3):387-8, 2009.
  • A13. “Comparison of outcomes of percutaneous nephrolithotomy on patients with normal and malformed kidneys,” Atmaca AF, Canda AE, Ozdemir AT, Serefoglu EC, Dogan B, Balbay MD. Turk J Med Sci. 39(4): 599-605, 2009.
  • A12. “Turkish validation of the Premature Ejaculation Diagnostic Tool and its association with intravaginal ejaculatory latency time,” Serefoglu EC, Cimen HI, Ozdemir AT, Symonds T, Berktas M, Balbay MD. Int J Impot Res. 21(2):139-44, 2009.
  • A11. “Uroflowmetric assessment of acute effects of sildenafil on the voiding of men with erectile dysfunction and symptomatic benign prostatic hyperplasia,” Guven EO, Balbay MD, Kilciler M, Serefoglu EC. Int Urol Nephrol. 41(2):287-92, 2009.
  • A10. “Penile blood cyclic guanosin monophosphate level is associated with penile Doppler ultrasound parameters,” Serefoglu EC, Erdamar H, Ozdemir AT, Atmaca AF, Berktas M, Balbay MD. Int J Impot Res. Jan-Feb;21(1):51-6, 2009.
  • A9. “Time-dependent changes in biomechanical properties of four different synthetic materials in a rabbit model and the importance in respect to sling surgery,” Atmaca AF, Serefoglu EC, Eroglu M, Gurdal M, Metin A, Kayigil O. Urol Int. 81(4):456-61, 2008.
  • A8. “Re: The 20-Core Prostate Biopsy Protocol - A New Gold Standard? V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod,” Serefoglu EC, Ozdemir AT, Balbay MD. J Urol. 180(5): 2256-7, 2008.
  • A7. “Re: Effect of Saw-Palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China,” Ozdemir AT, Serefoglu EC, Balbay MD. J Urol.;180(3):1188, 2008.
  • A6. “Clinicopathological features and survival rates of patients with renal cell carcinoma under 50 years of age,” Atmaca AF, Bayrak O, Kandemir O, Serefoglu EC, Culha IE, Canda AE, Balbay MD. Centr Eur J Med. 3(4): 453-8, 2008.
  • A5. “Re: Relationship Between Lower Urinary Tract Symptoms and Erectile Dysfunction: Results From the Boston Area Community Health Survey S. T. Brookes, C. L. Link, J. L. Donovan and J. B. McKinlay,” Serefoglu EC, Ozdemir AT, Balbay MD. J Urol. 180(2): 787-8, 2008.
  • A4. “Problems in understanding the Turkish translation of the International Index of Erectile Function,” Serefoglu EC, Atmaca AF, Dogan B, Altinova S, Akbulut Z, Balbay MD. J Androl. 29(4):369-73, 2008.
  • A3. “Ossification of renal cell carcinoma: a favorable marker,” Serefoglu EC, Yazgan AK, Altinova S, Ozdemir AT, Akincioglu E, Balbay MD. Centr Eur J Med. 41(1): 125-7, 2009.
  • A2. “Effects of transanal pelvic plexus stimulation on penile erection: clinical implications.” Kayigil O, Agras K, Gurdal M, Serefoglu EC, Okulu E, Ucgul Y. Int Urol Nephrol. 39(4): 1195-201, 2007.
  • A1. “Retroperitoneal textiloma mimicking a renal tumor: case report,” Agras K, Serefoglu EC, Duran E, Gurdal M, Kayigil O. Int Urol Nephrol. 39(2): 401-3, 2007.
Tümünü göster

Ödüller

  • Amsterdam Genç Bilimadamı Ödülü (2012)
  • Gilead Fellowship Award (2015)
Randevu al

Adres

Haritayı büyüt yeni bir sekmede açılır

valikonağı caddesi fulya sokak no: 2, Şişli, İstanbul

Uygunluk

Bu adres için online randevu takvimi mevcut değil

Kabul edilen hasta/danışanlar

  • Sigortasız hastalar
Haritayı büyüt yeni bir sekmede açılır

Adres bilgileri

Hizmetler

Henüz bir hizmet eklenmedi

Bu hekim/uzman, henüz verdiği hizmetlere dair bir bilgi girişi yapmadı.

Diğer içerikler

Makaleler

Makaleler

Yorumlar

Görüş ekle

5 görüş

  • I

    Diğer konular hakkında bi fikrim yok, ama gecikmiş boşalma gibi spesifik bi probleminiz varsa, kendisini tavsiye edemiyorum. Bana bi faydası olmadı.

     • • Diğer  • 
  • T

    Mikro tese ameliyatı için doktorunuza başvurduk. Çok iyi işinde çok başarılı doktorumuz. Doktor bey ve çalışma arkadaşları süreç boyunca hep bizi rahatlatarak, son dakikaya kadar elimizi asla bırakmayarak, mesajlarımıza hemen dönerek bizi hiç yalnız bırakmadılar ve hep rahatlattılar. Ameliyat başarısı olsun, sonraki süreci eşimin rahat atlatması olsun hep sizinle iyiki yollarımız kesişmiş diyoruz.

     • • Diğer  • 
  • B

    Öncesinde mikrotese operasyonu geçirmiş olan kardeşimin %25'lik başarı şansını kendisine yakalatabilmiş olan doktor beyi bir hekim olarak kesinlikle tavsiye ederim. Başarılarının devamını yürekten dilerim.

     • başka bir yer • Diğer  • 

    Prof. Dr. Ege Can Şerefoğlu

    Nazik yorumunuzu henüz gördüm. Çok teşekkür ederim. Kardeşinize (ve yeğeninize) sağlıklı bir ömür dilerim.

  • E

    Babamın yaşadığı prostat problemini yaptığı başarı operasyonla ve ilgisiyle yaşam kalitemizi artırdığı için kendisine teşekkür ediyoruz.

     • •  • 

    Prof. Dr. Ege Can Şerefoğlu

    Nazik yorumlarınız için teşekkürler Ertan Bey. Babanıza sağlıklı bir ömür dilerim.

  • A

    Amsterdam Genç Bilim Adamı ödülünü alan ilk türk doktor. Yığınla bilimsel araştırmaları vardır. Türkiyenin en ünlü üroloğu diyebiliriz sanırım. Ankara Medicana hastanesi üroloji departmanında tedavi olabilirsiniz kendisine

     • •  • 

    Prof. Dr. Ege Can Şerefoğlu

    Teşekkürler Aykut Bey. Artık başka bir merkezde gorev yapıyorum.

Hata oluştu, tekrar deneyin

Sıkça Sorulan Sorular

Yakınlardaki Ürologlar
Yakın zamanda aranan bazı hastalıklar
Sık kullanılan sigortalar

Payment for your appointment is required

Your specialist requests the payment of the appointment you have booked. To reschedule the appointment, please make the payment in advance or contact your specialist directly.
Ziyaretlerim Pay